Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-02-20 to 2025-02-21
Current total value of award: $7452.86
Description: 4567321989!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML